整合机器学习与in silico研究和量子化学:通过针对CDK2酶的多尺度查探索新型化合物
Priyanka Solanki1, Sk Abdul Amin2, Anu Manhas1
1Department of Chemistry, Pandit Deendayal Energy University, Gandhinagar, 382426, India.
Computers in biology and medicine
|July 10, 2025
概括
研究人员利用机器学习发现了针对循环林依赖激酶2 (CDK2) 的新型抗癌药物候选者. 一个随机的森林模型选了数百万个分子,识别了有前途的抑制剂以供进一步研究,并开发了一种可访问的选工具.
科学领域:
- 药用化学 医学化学
- 计算机化药物设计技术
- 在瘤学瘤学.
背景情况:
- 循环素依赖激酶2 (CDK2) 对于细胞循环进展至关重要,也是癌症治疗的关键标,因为它在不受控制的细胞增殖中的作用.
- CDK2活性失调是许多癌症的标志性特征,使其抑制成为重要的治疗策略.
研究的目的:
- 用全面的计算查管道识别CDK2的新型小分子抑制剂.
- 整合机器学习和分子建模技术,以高效地发现药物.
- 开发一个开放访问工具,用于预测潜在的CDK2抑制剂.
主要方法:
- 一个随机森林 (RF) 机器学习模型被开发和训练用于分类.
- 使用射频模型选了477975个分子的大数据集,随后进行了PAINS过.
- 被选中的候选人接受了分子对接,ADMET预测,DFT和分子动力学模拟.
主要成果:
- 射频模型有效地过了数据集,确定了327个初始候选者,在PAINS过后改进到309个.
- 分子对接确定了40个顶级候选人,其中3个正在通过ADMET,DFT和分子动力学研究.
- 最后三种化合物与关键的CDK2残留物 (Lys33,Asp145) 呈现稳定的相互作用,其中一种由于其结构而显示出增强的抑制潜力.
结论:
- 该研究通过综合计算方法成功识别了新的潜在CDK2抑制剂.
- 机器学习显著提高了抗癌剂药物发现管道的效率.
- 一个开放访问工具pCDK2i_v1.0被开发出来,以促进未来的CDK2抑制剂查研究.
相关概念视频
02:15M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
01:26Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K